Advertisement

Topics

Communications Sales & Leasing to Present at Stephens Spring Investment Conference 2015

20:00 EDT 31 May 2015 | Globe Newswire

LITTLE ROCK, Ark., June 1, 2015 (GLOBE NEWSWIRE) -- Communications Sales & Leasing, Inc. ("CS&L") (Nasdaq:CSAL) announced today that its President and Chief Executive Officer, Kenny Gunderman, is scheduled to present at the Stephens Spring Investment Conference 2015. The presentation is scheduled for 2:00pm (Eastern Time) on Tuesday, June 2, 2015.

You may access the webcast at http://wsw.com/webcast/stph24/csal, which link may also be found on CS&L's website at www.cslreit.com under the Investors tab and will be available for replay June 2, 2015 through June 12, 2015.

About CS&L

CS&L (Nasdaq:CSAL), an S&P 400 Midcap Index company headquartered in Little Rock, Ark., is an internally managed triple-net-lease real estate investment trust primarily engaged in the acquisition and leasing of communication distribution systems. CS&L currently owns 64,000 route miles of fiber, 235,000 route miles of copper and central office land and buildings across 29 states. Additional information about CS&L can be found on its website at www.cslreit.com.

CONTACT: Investor Contact:
         Rob Clancy, 501-850-0855
         VP - Investor Relations & Assistant Treasurer
         rob.clancy@cslreit.com
         
         Mark A. Wallace, 501-850-0866
         SVP, Chief Financial Officer & Treasurer
         mark.wallace@cslreit.com

Communications Sales & Leasing Inc. logo

NEXT ARTICLE

More From BioPortfolio on "Communications Sales & Leasing to Present at Stephens Spring Investment Conference 2015"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...

Mergers & Acquisitions
Commercial and market reports on mergers and acquisitions in the biotechnology, pharmaceutical, medical device and life-science industries. Mergers and acquisitions (abbreviated M&A;) is an aspect of corporate strategy, corporate finance and manageme...